Tag

Epic Research

All articles tagged with #epic research

health6 days ago•14 min saved

Epic Data Shows 1995 Chickenpox Vaccine Era Halved Shingles Rates in Young Adults

A massive analysis of 85 million U.S. medical records confirms that the 1995 introduction of the childhood chickenpox vaccine has significantly reduced shingles cases in adults under 35. While shingles rates are rising for older cohorts who contracted the virus naturally, younger generations vaccinated as children show a steep decline, with rates dropping by 62% between the mid-1990s and 2000s birth cohorts. This data supports the long-term protective benefits of early vaccination against the varicella-zoster virus.

via Gizmodo|

#chickenpox-vaccine #epic-research #health

health7 days ago•395 min saved

Epic Data Links Chickenpox Vaccine Era to Sharp Drop in Young Adult Shingles

A large analysis by Epic Research indicates that shingles cases are declining among adults aged 34 and younger, likely due to widespread chickenpox vaccination. While rates are falling for those under 35, they are rising for those over 35, who were less likely to be vaccinated as children. The chickenpox vaccine, introduced in 1995, prevents the varicella-zoster virus infection that can later reactivate as shingles. Experts note that while younger cohorts show lower risk, long-term protection remains unproven. Meanwhile, older adults face higher risks due to natural infection history and immune aging, though shingles vaccines like Shingrix remain recommended for those over 50.

via nbcnews.com|

#chickenpox-vaccine #epic-research #health

health4 months ago•16 min saved

GLP-1 Drugs Hint at Obesity Decline as Prescriptions Rise

New EPIC Research trackers using COSMOS data show GLP-1 prescriptions have risen fourfold since 2021, while obesity within the dataset declined from 42% to 41%, with GLP-1 users seeing a bigger drop (75% to 69%). While not nationally representative, the trend aligns with CDC estimates and other surveys that show rising GLP-1 use. Barriers like side effects, cost, and insurance limit adoption (about 12% of Americans), and cheaper generics abroad could arrive in five years. If adoption continues, obesity could decline further, though long-term effects remain uncertain.

via Gizmodo|

#epic-research #glp-1s #health

health5 months ago•4 min saved

Baby Aspirin Use for Heart Prevention Drops Significantly as Guidelines Tighten

A Epic Research analysis of about 279 million primary-care visits (2015–2025) shows daily low-dose aspirin use for preventing cardiovascular disease has roughly halved, dropping from about 7% in 2018 to 3% by 2025; guideline changes over the past decade discourage aspirin for primary prevention in favor of managing risk factors like cholesterol and blood pressure, while aspirin may still help for people who have already had a heart attack, stroke, or a stent, after individualized risk assessment.

via Women's Health|

#aspirin #epic-research #guidelines

health2 years ago•3 min saved

"Study: Majority Maintain Weight Loss After Stopping Ozempic and Wegovy"

A study from Epic Research suggests that a majority of people who stop taking GLP-1 drugs like semaglutide either maintain or improve their weight loss in the year after discontinuing the medication. While more than a third of former users did regain much or all of their original weight, the findings indicate that at least some people can successfully stop taking these drugs without losing the health benefits they provide. The study also suggests that there may be ways to improve the odds of sustained weight loss once the therapy is ended, such as through diet and exercise counseling.

via Gizmodo|

#epic-research #glp-1-drugs #health